Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,736
Total Claims
$1.9M
Drug Cost
480
Beneficiaries
$3,981
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 21,141 Psychiatry providers
+135%
Cost per patient vs peers
$3,981 vs $1,696 avg
+114%
Brand preference vs peers
10.6% vs 5.0% avg
Brand vs Generic
Brand: 924 claims · $1.7M
Generic: 7,812 claims · $214K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Valbenazine Tosylate | 40 | $435K |
| Deutetrabenazine | 37 | $260K |
| Brexpiprazole | 144 | $242K |
| Cariprazine Hcl | 120 | $186K |
| Deutetrabenazine | 12 | $77K |
| Vortioxetine Hydrobromide | 105 | $73K |
| Lumateperone Tosylate | 43 | $71K |
| Suvorexant | 136 | $69K |
| Lurasidone Hcl | 40 | $63K |
| Aripiprazole | 19 | $53K |
| Olanzapine/Samidorphan Malate | 20 | $32K |
| Aripiprazole | 368 | $27K |
| Memantine Hcl/Donepezil Hcl | 22 | $27K |
| Dextromethorphan Hbr/Quinidine | 20 | $23K |
| Clozapine | 13 | $19K |
Prescribing Profile
67
Unique Drugs
12.0
Anomaly Score
Patient Profile
63
Avg Age
69%
Female
1.70
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About